Medical Devices & Supplies · Medical Specialties · NSE: POLYMED · data 2026-10-30

Poly Medicure Limited

₹1,449.5-0.85% on 30 OctHealth: Average 5.1/10

Feb 2026Low ₹1,191.1 · High ₹1,869.4+4.3%

In plain words

Price: 30.8% below its 52-week high of ₹2,094.3.

Delivery: 52.4% of traded shares were kept for delivery over the last 10 sessions, against 48.3% over the last 60.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹1,449.5

Market cap

₹14,828 cr

P/E

46.7

P/B

—

ROE

11.0%

ROCE

10.9%

Debt / equity

0.11

Dividend yield

0.24%

1-year return

-26.5%

52-week high

₹2,094.3

52-week low

₹1,182

Operating margin

16.7%

Growth

Revenue (last 12 months)	₹1,997 cr
Net profit (last 12 months)	₹315 cr
Sales growth, 3 years (yearly)	18.8%
Profit growth, 3 years (yearly)	21.6%

Smart-money activity

19/100 · Weak over the last ~60 sessions, data 2026-10-30

Delivery vs usual 7/30: Delivery 53.8% over the last 20 sessions vs 42.3% in the 40 before (1.27x); shares delivered per day 0.59x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 7/15: 3 schemes hold it, about ₹201 cr in all (as of 2026-09-30). Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Story so far

● Dividend

28 Aug 26Dividend Dividend ₹3.5 (ex-date) +2.7% next session
18 Sept 25Dividend Dividend ₹3.5 (ex-date) 0.0% next session

From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.

Common questions

Is Poly Medicure Limited debt-free?

Its latest reported debt-to-equity ratio is 0.11.

What is Poly Medicure Limited's P/E ratio?

About 46.7, based on the last 12 months' earnings and a price of ₹1,449.5 (data 2026-10-30).

What is the 52-week high and low of Poly Medicure Limited?

The 52-week high is ₹2,094.3 and the 52-week low is ₹1,182.

Mutual funds holding Poly Medicure Limited

From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 3 schemes holding about ₹201 cr; funds that hold it outside their top holdings may not be listed.

Scheme	Fund house	% of fund	Value
SBI Healthcare Opportunities Fund	SBI Mutual Fund	1.82%	₹107 cr
SBI MNC Fund	SBI Mutual Fund	1.47%	₹94 cr
Mirae Asset Nifty 500 Healthcare ETF	Mirae Asset Mutual Fund	0.47%	₹0 cr

Similar companies

Lenskart Solutions Limited (LENSKART) · Molbio Diagnostics Limited (MOLBIO) · Standard Engineering Technology Ltd (SETL) · Sahajanand Medical Technologies Limited (SMT) · Virtuoso Optoelectronics Limited (VOEPL)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open POLYMED in NSE Scanner →